Individual generic drug information
Extracted information for Insulin glargine only.
Diabetes mellitus ▶BY SUBCUTANEOUS INJECTION ▶Child 2–17 years: According to requirements ▶Adult: According to requirements TOUJEO ® Diabetes mellitus ▶BY SUBCUTANEOUS INJECTION ▶Adult: According to requirements
Source page 779
Insulin glargine is a biological medicine. Biological medicines must be prescribed and dispensed by brand name, see Biological medicines and Biosimilar medicines, under Guidance on prescribing p. 1. Dose adjustments and close metabolic monitoring is recommended if switching between insulin glargine preparations.
Source page 779
Scottish Medicines Consortium (SMC) decisions The Scottish Medicines Consortium has advised that Lantus ® preparations (April 2013) and Toujeo ® (August 2015) are accepted for restricted use within NHS Scotland for the treatment of type 1 diabetes: . in those who are at risk of or experience unacceptable frequency or severity of nocturnal hypoglycaemia on attempting to achieve better hypoglycaemic control during treatment with other insulins . as a once daily insulin therapy for patients who require a carer to administer their insulin It is not recommended for routine use in patients with type 2 diabetes unless they suffer from recurrent episodes of hypoglycaemia or require assistance with their insulin injections.
Source page 779
Extracted information for Insulin glargine only.
→Appendix 1: insulins
Source page 779
▶Rare or very rare Myalgia. sodium retention. taste altered
Source page 779
Evidence of the safety of long-acting insulin analogues in pregnancy is limited, therefore isophane insulin is recommended where longer-acting insulins are needed; insulin detemir may also be considered.
Source page 779
Extracted information for Insulin glargine only.
There can be variation in the licensing of different medicines containing the same drug. Solution for injection ▶Abasaglar (Eli Lilly and Company Ltd) Insulin glargine 100 unit per 1 ml Abasaglar 100units/ml solution for injection 3ml cartridges | 5 cartridge P £35.28 DT = £37.77 ▶Abasaglar KwikPen (Eli Lilly and Company Ltd) Insulin glargine 100 unit per 1 ml Abasaglar KwikPen 100units/ml solution for injection 3ml pre-filled pens | 5 pre-filled disposable injection P £35.28 DT = £37.77 ▶Lantus (Sanofi) Insulin glargine 100 unit per 1 ml Lantus 100units/ml solution for injection 3ml cartridges | 5 cartridge P £37.77 DT = £37.77 Lantus 100units/ml solution for injection 3ml pre-filled SoloStar pens | 5 pre-filled disposable injection P £37.77 DT = £37.77 Lantus 100units/ml solution for injection 10ml vials | 1 vial P £27.92 DT = £27.92 ▶Semglee (Mylan) A Insulin glargine 100 unit per 1 ml Semglee 100units/ml solution for injection 3ml pre-filled pens | 5 pre-filled disposable injection P £29.99 DT = £37.77 Endocrine system ▶Toujeo (Sanofi) Insulin glargine 300 unit per 1 ml Toujeo 300units/ml solution for injection 1.5ml pre-filled SoloStar pens | 3 pre-filled disposable injection P £32.14 DT = £32.14 ▶Toujeo DoubleStar (Sanofi) Insulin glargine 300 unit per 1 ml Toujeo 300units/ml solution for injection 3ml pre-filled DoubleStar pens | 3 pre-filled disposable injection P £64.27 DT = £64.27
Source page 779
Filter the extracted dose blocks for this individual drug.
First line only; read the complete Indications and dose section above.
According to requirements
This is a first-line fragment. Read the full Indications and Dose section above.
Candidate age grouping · source page 779
First line only; read the complete Indications and dose section above.
According to requirements
This is a first-line fragment. Read the full Indications and Dose section above.
Candidate age grouping · source page 779
First line only; read the complete Indications and dose section above.
According to requirements
This is a first-line fragment. Read the full Indications and Dose section above.
Candidate age grouping · source page 779
